Abstract:Background The growth and metastasis of tumors depend on the development of an adequate blood supply via angiogenesis. Recent studies indicate that the inducible nitric oxide synthase (iNOS), vascular endothelial growth factor (VEGF) and the tumor suppressor p53 are fundamental play-markers of the angiogenic process. Overexpression of iNOS and VEGF has been shown to induce angiogenesis in tumors. P53 suppresses angiogenesis by down-regulating VEGF and iNOS. The correlation of expression of p53, VEGF and iNOS and clinical features in gastric carcinogenesis, however, has not been well characterized. Methods The expression of p53, iNOS and VEGF in gastric precancerous and cancerous lesions and its relation with the clinical features was determined with immunohistochemistry (avidin-biotin-peroxidase complex method) on 55 randomly selected GC patients and 60 symptom-free subjects from the mass survey in the high-incidence area for GC in Henan, northern China. Results The positive immunostainig rates for p53, iNOS and VEGF in gastric carcinomas were 51%, 44% and 51%, respectively, and correlated well with TNM stages, but did not show significant difference among the groups with different degrees of gastric wall invasion depth by GC. A positive immunostaining reaction for the iNOS protein was significantly correlated with lymph node metastasis (p = 0.019; Spearman correlation coefficient). P53 protein accumulation was higher in the poorly-differentiated gastric carcinoma than in well-differentiated one. In gastric biopsies, no positive immunosatining was observed for p53, iNOS and VEGF in the histologically normal tissue and chronic superficial gastritis (CSG). However, p53, iNOS and VEGF positive immunostaining was observed in the tissues with different severities of lesions of chronic atrophic gastritis (CAG), intestinal metaplasia (IM) and dysplasia (DYS), and the positive rates increased with the lesion progression from CAG to IM to DYS. A high coincidental positive and negative immunostaining rate for p53, iNOS and VEGF was observed both in biopsy samples with CAG, IM and DYS from the symptom-free subjects and in gastric cancer tissue from the GC patients. Conclusions The present results indicated that p53 protein accumulation and increased expression of iNOS and VEGF might be responsible for gastric carcinogenesis and tumor aggressiveness of gastric cancer.

Alterations of IMP1 Protein in Esophageal and Gastric Cardia Cancer and Precancerous Lesions

Expression of MDR1mRNA detected and its correlation with p53 in esophageal carcinoma by in situ hybridization

Expression of Id-1 Protein in Esophageal Cancer and Precancerous Lesion Tissue

Expression of Id-1 Mrna in Esophageal Cancer and Immortalized Cell Lines and in the Esophageal Cancer and Adjacent Cancer Tissue

Expression of P53, Inducible Nitric Oxide Synthase and Vascular Endothelial Growth Factor in Gastric Precancerous and Cancerous Lesions: Correlation with Clinical Features

IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis

Proteins Profile in Esophageal Multistage Carcinogenesis

Expression of Upa and PAI-1 in Different Stages of Carcinogenesis and Progression of Esophageal Cancer

Expressions of SIRT 1, E-cadherin and MLH 1 in Gastric Cardia Carcinoma and Their Relationship

[Alteration of Early Growth Response 1 Expression in Gastroenterological Cancers and Its Biological Significance].

Prognostic Value of the IASLC/ATS/ERS Classification and IMP3 Expression in Lung Adenocarcinoma of Chinese Cases.

IMP3 is a novel biomarker to predict metastasis and prognosis of tongue squamous cell carcinoma.

The determination of p53 protein and VEGF and MVD in esophageal squamous cell carcinoma and adjacent noncancerrous tissue and their relations

NF-κBp65/p50 Protein Expression in Esophageal Cancer and Precancerous Lesions at High Incidence Area in Henan

Differential Expression and Significance of Endoplasmic Reticulum Golgi Intermediate Compartment 1 in Precancerous Gastric Lesions and Gastric Cancer.

P53immunostaining Positive Cells Correlated Positively with S Phase Cells As Measured by BrdU in the Esophageal Precancerous Lesions from the Subjects at High Incidence Area for Esophageal Cancer in Northern China

Decreased Expression of CIAPIN1 Is Correlated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma

Overexpression of Id-1 in gastric adenocarcinoma: implication for a novel diagnostic marker.

Prognosis of intestinal metaplasia and expressions of biomarkers in high-risk populations of gastric cancer in Shangdong province

Expression of 1A6 Gene and Its Correlation with Intestinal Gastric Carcinoma

Insulin-like Growth Factor-Ii Mrna-Binding Protein 3 Predicts a Poor Prognosis for Colorectal Adenocarcinoma